Multiple Sclerosis Comprehensive Update

This session is one of four sessions that make up the full course "Multiple Sclerosis Comprehensive Update: Overview of Clinical Management, Therapeutic Strategies and Research Trends." Learners have the option of registering for the full course or registering for the four sessions individually.

Disclosure Policy

All individuals in a position to control the content of this activity have been asked to disclose any relationship they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The following planners, speakers, and content reviewers have reported relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated:

NAME COMPANY RELATIONSHIP
Course Planners    
Tanuja Chitnis, MD, MA, FAAN Novartis Advisory Board/Committee, Consultant
  Sanofi Advisory Board/Committee, Consultant
  Sanofi Research Support
  Novartis Research Support
  Octave Research Support
  Roche Genentech  Consultant
  I-Mab Biopharma Research Support
  Roche Genentech Research Support
  Tiziana Life Sciences Research Support, Consultant
     
Maria Houtchens, MD, MSc Biogen Research Support, Consultant
  Genzyme Research Support
  Serono Consultant
  Roche Research Support, Advisory Board/Committee
  Novartis Research Support
     
Course Faculty    
Shamik Bhattacharyya, MD Alexion Pharmaceuticals Research Support
     
Michael Levy, MD, PhD Alexion Research Support, Consultant
  Genetech Consultant, Research Support
  Horizon Consultant
  Horizon Research Support
  UCB Investigator
  Sanofi Investigator
     
Christopher Severson, MD Novartis Advisory Board/Committee
  Biogen Advisory Board/Committee
  Roche/Genentech Advisory Board/Committee
  Sanofi/Genzyme Advisory Board/Committee
     
Jonathan Zurawksi, MD Novartis Pharmaceutical Research Support

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.